It’s the start of the new fiscal year here in the UK and it seems like private equity also has tax on its mind.
The success in intra-European healthcare deals requires regulatory expertise, operational flexibility and market-specific ...
With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...
As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, ...
On 26 March 2025, the European Council approved its position, known as a “negotiating mandate”, on a key element of the ...
The European Data Protection Board (EDPB) recently announced the launch of its 2025 Coordinated Enforcement Framework (CEF) ...
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
Evolving regulations and market requirements have kept medtech companies on their toes for years. EU MDR, for example, has ...
March 26, 2025, marked a pivotal moment in the EU with the European Health Data Space Regulation, (EU) 2025/327 (“EHDS Regulation”), coming ...
Switzerland is working toward reestablishing its relationship with the EU while exploring new avenues. Meanwhile, the U.K. is ...
6d
Pharmaceutical Technology on MSNEU Health Data Space strikes a chord in EU harmonisation plansEU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results